Log in


arizona asthma coalition

European regulators to review GSK's asthma drug Nucala to treat COPD

April 14, 2025 10:42 AM | AAC (Administrator)

Shared from Reuters

The European Medicines Agency will review GSK's (GSK.L), opens new tab request to approve its asthma drug Nucala as an additional treatment for chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype, the British drugmaker said on Monday.

Read more

About the Coalition

As a nonprofit partnership since 1996, AAC has worked together with concerned stakeholders including public health, environmental quality, managed care, education, individual physicians and nurses, hospitals, foundations, families and other colleagues.

Contact

azasthmacoalition@gmail.com
480-447-6978

Arizona Asthma Coalition

Attn: Andrew Arthur, MD

839 W. Congress St.

Tucson, AZ 85745


Copyright © 2018. Arizona Asthma Coalition.


Powered by Wild Apricot Membership Software